TREatment of degeNerative and Neoplastic Diseases With Rituximab

Clinical trial NCT01277172 · UNKNOWN

Trial details

NCT number: NCT01277172
Sponsor: Probiomed S.A. de C.V.
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2010-10-01
Primary completion: 2011-09-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.